DK0573510T3 - Antivækstfaktor antistoffer i behandlingen af vaskulær stenose - Google Patents

Antivækstfaktor antistoffer i behandlingen af vaskulær stenose

Info

Publication number
DK0573510T3
DK0573510T3 DK92905617.4T DK92905617T DK0573510T3 DK 0573510 T3 DK0573510 T3 DK 0573510T3 DK 92905617 T DK92905617 T DK 92905617T DK 0573510 T3 DK0573510 T3 DK 0573510T3
Authority
DK
Denmark
Prior art keywords
growth factor
vascular stenosis
treatment
antibodies
factor antibodies
Prior art date
Application number
DK92905617.4T
Other languages
Danish (da)
English (en)
Inventor
Russell Ross
Michael A Reidy
Elaine W Raines
Volkhard Lindner
Gordon A A Ferns
Christopher Jackson
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Washington filed Critical Univ Washington
Application granted granted Critical
Publication of DK0573510T3 publication Critical patent/DK0573510T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK92905617.4T 1991-01-17 1992-01-17 Antivækstfaktor antistoffer i behandlingen af vaskulær stenose DK0573510T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US64175891A 1991-01-17 1991-01-17

Publications (1)

Publication Number Publication Date
DK0573510T3 true DK0573510T3 (da) 1998-04-27

Family

ID=24573729

Family Applications (2)

Application Number Title Priority Date Filing Date
DK92905617.4T DK0573510T3 (da) 1991-01-17 1992-01-17 Antivækstfaktor antistoffer i behandlingen af vaskulær stenose
DK97106298T DK0798002T3 (da) 1991-01-17 1992-01-17 Anti-blodpladeafledtvækstfaktor-antistoffer til behandling af restenose

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK97106298T DK0798002T3 (da) 1991-01-17 1992-01-17 Anti-blodpladeafledtvækstfaktor-antistoffer til behandling af restenose

Country Status (10)

Country Link
US (1) US5648076A (es)
EP (2) EP0798002B1 (es)
JP (2) JP3667752B2 (es)
AT (2) ATE216592T1 (es)
AU (1) AU665529B2 (es)
CA (1) CA2100876A1 (es)
DE (2) DE69232579T2 (es)
DK (2) DK0573510T3 (es)
ES (2) ES2117046T3 (es)
WO (1) WO1992012734A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770198A (en) * 1988-05-18 1998-06-23 The Research Foundation Of The State Of New York Platelet-specific chimeric 7E3 immunoglobulin
EP0835135A2 (en) * 1995-06-07 1998-04-15 Centocor, Inc. Platelet-specific chimeric immunoglobulin and methods of use therefor
US7241568B2 (en) 1996-04-03 2007-07-10 Kyowa Hakko Kogyo Co., Ltd. Anti-fibroblast growth factor-8 monoclonal antibody
WO1998035697A1 (en) * 1997-02-14 1998-08-20 Roche Diagnostics Gmbh Improved method for the reduction of neointima formation after angioplasty
JP4152315B2 (ja) * 2001-06-28 2008-09-17 協和醗酵工業株式会社 線維芽細胞増殖因子−8に対するヒト化抗体および該抗体断片
EP2060270A3 (en) * 2003-10-16 2009-12-09 Imclone LLC Fibroblast growth factor receptor-1 inhibitors and methods of treatment thereof
US9339593B2 (en) * 2007-01-11 2016-05-17 Robert L. Bjork, JR. Drug-eluting coronary artery stent coated with anti-platelet-derived growth factor antibodies overlaying extracellular matrix proteins with an outer coating of anti-inflammatory (calcineurin inhibitor) and/or anti-proliferatives
WO2008086490A2 (en) * 2007-01-11 2008-07-17 Robert Lamar Bjork, Jr Multiple drug-eluting coronary artery stent for percutaneous coronary artery intervention
WO2016149103A1 (en) * 2015-03-13 2016-09-22 The Regents Of The University Of California Monoclonal antibody for prevention and/or treatment of astrovirus disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0288687B1 (en) * 1987-03-03 1994-12-28 Takeda Chemical Industries, Ltd. Monoclonal antibody, hybridoma, their production and use thereof
CA1339356C (en) * 1988-02-02 1997-08-26 Lewis T. Williams Human platelet-derived growth factor receptor
US5268358A (en) * 1988-12-08 1993-12-07 Cor Therapeutics, Inc. PDGF receptor blocking peptides
AU6605690A (en) * 1989-10-27 1991-05-31 Du Pont Merck Pharmaceutical Company, The Monoclonal antibodies to basic fibroblast growth factor that inhibit its biological activity
JP4350370B2 (ja) * 2002-12-27 2009-10-21 株式会社半導体エネルギー研究所 電子回路及び電子機器

Also Published As

Publication number Publication date
AU1327492A (en) 1992-08-27
ES2174144T3 (es) 2002-11-01
DE69232579T2 (de) 2002-08-22
ATE216592T1 (de) 2002-05-15
EP0573510A1 (en) 1993-12-15
EP0573510B1 (en) 1998-04-01
EP0798002A1 (en) 1997-10-01
ES2117046T3 (es) 1998-08-01
US5648076A (en) 1997-07-15
JPH06504551A (ja) 1994-05-26
CA2100876A1 (en) 1992-07-18
WO1992012734A1 (en) 1992-08-06
DK0798002T3 (da) 2002-08-19
EP0798002B1 (en) 2002-04-24
AU665529B2 (en) 1996-01-11
JP2002316945A (ja) 2002-10-31
JP3667752B2 (ja) 2005-07-06
DE69224983T2 (de) 1998-07-30
ATE164521T1 (de) 1998-04-15
DE69224983D1 (de) 1998-05-07
DE69232579D1 (de) 2002-05-29

Similar Documents

Publication Publication Date Title
DE69229539D1 (de) Okklusionsvorrichtung zur Reparatur von Herz- und Gefäss-Defekten
DE69226841D1 (de) Okklusionsvorrichtung zur Reparatur von Herz- und Gefäss-Defekten
DE69220355D1 (de) Selbstausspreizbare, vaskuläre Endoprothese
ITTO930940A0 (it) Innesto protesico vascolare
DE69227396D1 (de) Gefässimplantat mit Verzweigung
SE8803472D0 (sv) Anvaendning av gamma-interferon foer behandling av vaskulaer stenos
DE69425531D1 (de) Vaskulärer Katheter
DE69207414D1 (de) Blutfilter
DE69322862D1 (de) Vaskulares implantatsystem
DK0573510T3 (da) Antivækstfaktor antistoffer i behandlingen af vaskulær stenose
IT8948423A0 (it) Complesso di filtro e suo impiego per la estrazione di oggetti ingombranti da acque di scarico
ATE174221T1 (de) Behandlung von pankreaskrankheit mit 15-keto- prostaglandin e-derivaten
AU6178094A (en) Polyurethane-coated intravascular prostheses (stents) for the treatment of blood vessel stenosis
EP0363671A3 (de) Verwendung von ACE-Inhibitoren gegen Neointimabildung nach Gefässverletzung
DE69206397D1 (de) Intrakondyläre Knie-Totalprothese.
DK0551729T3 (da) gamma-linolensyre til fremstilling af et medikament til forhindring af reokklusion af arterier
NO913117D0 (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
DK0661981T3 (da) Anvendelse af hyaluronsyre og derivater heraf til forebyggelse mod arteriel restenose
NO892548L (no) Fremgangsmaate for fiksering av krominneholdende kobberarsenatbehandlende midler i tre.
NO932346D0 (no) Sluttstykke for ammunisjons-utkastingsroer med tilhoerende utkastingsroer
FR2669539B1 (fr) Dispositif pour la circulation artificielle du sang et transfuseur autologue de sang total.
FR2630850B1 (fr) Tube electronique pour la detection, la memorisation, et la selection d'images lumineuses
DK417889A (da) Anvendelse af 2-azabicyklo(2.2.2.)-carboxylsyrederivater til fremstilling af medicinske produkter til behandling af vaskulaere sygdomme
NO933419D0 (no) Vaskulaer protese
ITBS920070V0 (it) Catetere per la disostruzione delle arterie